Therapie Morbus-Crohn-bedingter Stenosen

Schlüsselwörter

Morbus Crohn - intestinale Stenose - Biologika - Immunsuppressiva - endoskopische Dilatation

Keywords

Crohn’s disease - intestinal stenosis - biologics - immunosuppressants - endoscopic dilatation

• Literatur

• 1 Appau KA, Fazio VW, Shen B et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn’s patients. J Gastrointest Surg 2008; 12: 1738-1744
• 2 Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 2000; 231: 38-45
• 3 Blomberg B, Rolny P, Järnerot G. Endoscopic treatment of anastomotic strictures in Crohn’s disease. Endoscopy 1991; 23: 195-198
• 4 Brooker JC, Beckett CG, Saunders BP et al. Long-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures may improve the outcome. Endoscopy 2003; 35: 333-337
• 5 Couckuyt H, Gevers AM, Coremans G et al. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective longterm analysis. Gut 1995; 36: 577-580
• 6 De Buck van Overstraeten A, Wolthuis A, D’Hoore A. Surgery for Crohn’s disease in the era of biologicals: a reduced need or delayed verdict?. World J Gastroenterol 2012; 18: 3828-3832
• 7 Dear KL, Hunter JO. Colonoscopic hydrostatic balloon dilatation of Crohn’s strictures. J Clin Gastroenterol 2001; 33: 315-318
• 8 Di Nardo G, Oliva S, Passariello M et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn’s disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc 2010; 72: 1201-1208
• 9 Dignass A, Van Assche G, Lindsay JO et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Current management. J Crohns Colitis 2010; 4: 28-62
• 10 East JE, Brooker JC, Rutter MD et al. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn’s strictures. Clin Gastroenterol Hepatol 2007; 5: 1065-1069
• 11 Eshuis EJ, Bemelman WA, van Bodegraven AA et al. Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn’s disease: a randomized multicenter trial (LIR!C-trial). BMC Surg 2008; 8: 15
• 12 Ferlitsch A, Reinisch W, Püspök A et al. Safety and efficacy of endoscopic balloon dilation for treatment of Crohn’s disease strictures. Endoscopy 2006; 38: 483-487
• 13 Gustavsson A, Magnuson A, Blomberg B et al. Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn’s disease. Aliment Pharmacol Ther 2012; 36: 151-158
• 14 Hassan C, Zullo A, De Francesco V et al. Systematic review: Endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther 2007; 26: 1457-1464
• 15 Hoffmann JC, Preiss JC, Autschbach F et al. [Clinical practice guideline on diagnosis and treatment of Crohn’s disease]. Z Gastroenterol 2008; 46: 1094-1146
• 16 Jeejeebhoy KN, Detsky AS, Baker JP. Assessment of nutritional status. JPEN J Parenter Enteral Nutr 1990; 14 (Suppl. 01) 193S-196S
• 17 Junge U, Züchner H. [Endoscopic balloon dilatation of symptomatic strictures in Crohn’s disease]. Dtsch Med Wochenschr 1994; 119: 1377-1382
• 18 Lavy A. Triamcinolone improves outcome in Crohn’s disease strictures. Dis Colon Rectum 1997; 40: 184-186
• 19 Louis E, Collard A, Oger AF et al. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-782
• 20 McLeod RS, Wolff BG, Ross S et al. Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum 2009; 52: 919-927
• 21 Mueller T, Rieder B, Bechtner G et al. The response of Crohn’s strictures to endoscopic balloon dilation. Aliment Pharmacol Ther 2010; 31: 634-639
• 22 Myrelid P, Olaison G, Sjödahl R et al. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn’s disease. Dis Colon Rectum 2009; 52: 1387-1394
• 23 Ramboer C, Verhamme M, Dhondt E et al. Endoscopic treatment of stenosis in recurrent Crohn’s disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc 1995; 42: 252-255
• 24 Scimeca D, Mocciaro F, Cottone M et al. Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn’s disease strictures. Dig Liver Dis 2011; 43: 121-125
• 25 Singh VV, Draganov P, Valentine J. Efficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn’s disease strictures. J Clin Gastroenterol 2005; 39: 284-290
• 26 Thienpont C, D’Hoore A, Vermeire S et al. Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut 2010; 59: 320-324
• 27 Thomas-Gibson S, Brooker JC, Hayward CMM et al. Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol 2003; 15: 485-488
• 28 Tilney HS, Constantinides VA, Heriot AG et al. Comparison of laparoscopic and open ileocecal resection for Crohn’s disease: a metaanalysis. Surg Endosc 2006; 20: 1036-1044
• 29 Weimann A, Braga M, Harsanyi L et al. ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr 2006; 25: 224-244
• 30 Wibmer AG, Kroesen AJ, Gröne J et al. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease – review of the literature. Int J Colorectal Dis 2010; 25: 1149-1157
• 31 Williams AJ, Palmer KR. Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn’s disease. Br J Surg 1991; 78: 453-454